Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer

Epidermal growth factor receptor (EGFR) mutations are common driver genes in nonsmall-cell lung cancer and have different sensitivities to EGFR-tyrosine kinase inhibitors (EGFR-TKIs). EGFR is divided into classic mutations and rare mutations. Classic mutations are well known, but the understanding o...

Full description

Bibliographic Details
Main Authors: Limeng Yu MM, Ruilin Wang MM, Yuhua Zhao MM, Yingxi Wu PhD, Lili Wang PhD, Haiyang Chen PhD, Zhen He PhD, Qiming Wang PhD, Yufeng Wu PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-04-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338231168466

Similar Items

Similar Items